Elektrofi Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Elektrofi is a biotechnology company focused on reformulating biologic therapies for subcutaneous delivery. Its platform supports high-concentration formulations designed to enable at-home self-administration, addressing the challenges associated with intravenous dosing of complex biologics. The company concentrates on monoclonal antibodies, therapeutic proteins, and other large-molecule drugs, and collaborates with strategic partners to develop and commercialize subcutaneous biologics. Headquartered in Boston, Massachusetts, Elektrofi operates within the biotechnology research ecosystem and seeks patient-centered approaches to drug delivery. Its customer base consists of biopharmaceutical developers seeking convenient, patient-friendly options for administering biologics, with the aim of expanding at-home usage. In April 2026, Elektrofi disclosed a partnership with Vertex Pharmaceuticals to advance its subcutaneous delivery capabilities.